Icosagen (Estonia)
Icosagen is an Estonian biotechnology companies providing custom research programs and services to the Biopharmaceutical industry, including antibody discovery, protein production, and GMP manufacturing. Formed in 1999 as Quattromed AS, it was renamed Icosagen in 2009. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Icosagen (Estonia), Estonia, covering academic research published from 2004 to 2024. Read More.
Open Access Percentage
77%
Total
Publications
75
Total Open
Publications
58
Total
Citations
1.3K
Open Access
Percentage
77%
Total
Publications
75
Total Open
Publications
58
Total
Citations
1.3K
Breakdown
Publisher Open
22%
Both
51%
Other Platform Open
3%
Closed
24%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 67%
34
Hybrid 23%
12
No Guarantees 10%
5
Other Platform Open
Domain 74%
28
Institution 42%
16
Other Internet 29%
11
Public 8%
3
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 28 |
DOI | Other Internet | 11 |
DANS - Data Archiving and Networked Services | Institution | 5 |
ntnu.no OAI-PMH Repository | Institution | 3 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 3 |
Figshare | Public | 3 |
University of Tartu - DSpace repository | Institution | 2 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 2 |
Maastricht University - Research Publications | Institution | 2 |
Europe PMC | Domain | 2 |